Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × pegfilgrastim × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Rhabdomyosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Burkitt Lymphoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡